Download
1 / 4
40 likes | 43 Views
Depression treatment is facing stiff decline. The depression treatment market is expected to grow at low CAGR of 2.1% for the forecasted period of 2018-2023. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and the growing strength of generic drug manufacturers. The patent cliff has caused a decline in revenues ranging from a few million dollars to billions. The patent expiration and generic drug manufacturers gaining the license to manufacturers have forced many branded drug manufacturers to either stop their R&D or to reduce budgets. <br><br>Browse full report at https://www.omrglobal.com/industry-reports/depression-treatment-market
E N D
Orion Market Research Depression Treatment Therapy Market, by Depression Type, by Drugs Type, by Depression Treatment Device - Global Industry Share, Growth, Competitive Analysis and Forecast, 2018-2023 ------------------------------------------------------------------------------------ Email: info@omrglobal.com Phone: +91 780-304-0404, +1 646-755-7667 The depression treatment therapy marketis estimated to grow moderately over the forecast period. Rapidly increasing cases of depression and innovations in drugs and therapies for anxiety disorders have been some of the primary drivers of the depression treatment therapy industry. Depression is growing to be one of the most significant contributors to the burden of diseases globally. Depression is affecting individuals all across the globe, with an estimated 350 million suffering from it, according to WHO (World
Health Organization). According to a survey carried out in 17 countries by WHO, it was reported that on an average 1 in every 20 individuals had a depression event in 2017. The demand for restricting depression and other lethal mental health disorders is on the rise globally, which is fuelling the depression treatment therapy market. Browse the full report description of “Depression Treatment Therapy Market, by Depression Type, by Drugs Type, by Depression Treatment Device - Global Industry Share, Growth, Competitive Analysis and Forecast, 2018-2023” at https://www.omrglobal.com/industry-reports/depression-treatment-market The emerging organizations' investments for drug and therapy development in psychiatric disorders and depression seem to be at a significant incline over the last decade. Perseverance of this trend is expected to have positive implications for the future output of ground-breaking drugs and medicines in curing mental health disorder. However, there is still a significant unfulfilled need for new drugs and therapies for the treatment of mental health disorders. According to WHO, as of 2019, there are only 29 active approved substances for major depression since 1959. Additionally, a unique molecular target-based prospective new therapeutic approaches and procedures have witnessed a considerable number of setbacks. Presently, 33 drug programs are in clinical trials and using new therapeutic approaches for depression. To know more information, please request a free report sample https://www.omrglobal.com/request- sample/depression-treatment-market Recent investment levels, R&D trends, and depth of existing clinical pipeline could impede the way for future innovations in depression therapeutics. There has been a significant drop in clinical trial initiations over the last few years for novel drug candidates in depression. Enterprise expenditures into companies with depression focused programs have nearly non-existent over the past few years. Further, the limits of currently available drugs for depression imply thatfurther therapeutic choices are in demand to address patients' needs. This patient need presents a lucrative opportunity for organizations desiring to enter the depression treatment therapy market. Current Market Trends Covered in the market report: •Increasing Cases of Anxiety Disorders and Depression •Unfulfilled Need for New Drugs and Therapies for the Treatment of Mental Health Disorders •Ongoing Clinical Trials for Depression Therapeutics Global Depression Treatment Therapy Market - Segmentation By Depression Type •Seasonal Affective Disorder (SAD) •Major Depression
•Dysthymia Disorder •Postpartum Depression •Atypical Depression •Psychotic Depression •Bipolar Disorder By Drugs Type •Selective Serotonin Reuptake Inhibitors •Atypical Antidepressants •Tricyclic Antidepressants By Depression Treatment Device •Transcranial Magnetic •Deep Brain Stimulator •Virtual Reality Therapy •Vagus Nerve Stimulator •Smart Phone Applications •Others Devices Visit https://www.omrglobal.com/industry-reports/depression-treatment-market here to know more about Depression Treatment Therapy Market study Global Depression Treatment Therapy Market – Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe
Asia-Pacific •China •India •Japan •Rest of Asia-Pacific Rest of the World •Middle East & Africa •Latin America About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404 Source: Depression Treatment Therapy Market
